IP Library Patent Application 17181787
Patent Application
App. No. 17/181,787

POLYMERASE ENZYME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/181,787
Abstract

The present invention relates to a family B polymerase enzyme comprising the following mutations, a mutation in the motif A region, wherein a threonine is the second amino acid of the motif A region, wherein the motif A region is homologous to amino acids 408 to 410 in 9° N, a mutation leading to a reduction or elimination of the 3′-5′ exonuclease activity if present in said family B polymerase, wherein said polymerase additionally comprises one or both of the following mutations in the motif A region, L408Y or L408F and/or P410S or P410G. It may be used in DNA sequencing and may be present in a kit.

Claims (11)

1 . A family B polymerase enzyme comprising the following mutations, a mutation in the motif A region, wherein a threonine is the second amino acid of the motif A region, wherein the motif A region is homologous to amino acids 408 to 410 in 9° N, a mutation leading to a reduction or elimination of the 3′-5′ exonuclease activity if present in said family B polymerase, wherein said polymerase additionally comprises one or both of the following mutations in the motif A region, L408Y or L408F and/or P410S or P410G.

2 . The polymerase of claim 1 wherein the polymerase is selected from the group consisting of 9° N polymerase having the mutation Y409T, Vent polymerase having the mutation Y412T, Pfu polymerase having the mutation Y410T, JDF-3 polymerase having the mutation Y409T and Taq polymerase having the mutation E615T.

3 . Polymerase according to claim 1 , wherein the polymerase comprises one or more of the following mutations D215A and/or D315A.

4 . Polymerase according to any of the claim 1 , wherein the polymerase additionally comprises a mutation A485L.

5 . Polymerase according to claim 1 , wherein the enzyme has the following set of mutations, (i) D215A, D315A, L408Y, Y409T, P410S and A485L or, (ii) D215A, D315A, L408F, Y409T, P410G and A485L.

6 . The polymerase according to claim 1 , which exhibits an increased rate of incorporation of nucleotides which have been modified at the 3′ sugar hydroxyl such that the substituent is larger in size than the naturally occurring 3′ hydroxyl group, compared to the control polymerase.

7 . A nucleic acid molecule encoding a polymerase according to claim 1 .

8 . An expression vector comprising the nucleic acid molecule of claim 7 .

9 . A method for incorporating nucleotides which have been modified at the 3′ sugar hydroxyl such that the substituent is larger in size than the naturally occurring 3′ hydroxyl group into DNA comprising the following substances (i) a polymerase according to claim 1 , (ii) template DNA, (iii) one or more nucleotides, which have been modified at the 3′ sugar hydroxyl such that the substituent is larger in size than the naturally occurring 3′ hydroxyl group.

10 . Use of a polymerase according to claim 1 for DNA sequencing, DNA labeling, primer extension, amplification or the like.

11 . Kit comprising a polymerase according to claim 1 .

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2023
From: PEIST, RALF; NARZ, FRANK; GRASSE, NICOLE; SCHIEREN, ANNE; RUTJES, THEA
To: QIAGEN GMBH
Reel/Frame 064416/0778 →
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Sep 2, 2021
From: QIAGEN GMBH
To: ISOPLEXIS CORPORATION
Reel/Frame 057395/0343 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →